# Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)

> **NCT00987831** · PHASE1,PHASE2 · COMPLETED · sponsor: **Oklahoma Medical Research Foundation** · enrollment: 158 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **OTHER:** Group B SLE one blood donation
- **OTHER:** Blood drawing only Group C
- **DRUG:** Group A SLE prospective study

## Key facts

- **NCT ID:** NCT00987831
- **Lead sponsor:** Oklahoma Medical Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2014-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00987831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00987831, "Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00987831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*